For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260330:nRSd5288Ya&default-theme=true
RNS Number : 5288Y 3i Group PLC 30 March 2026
Director/PDMR Shareholding
UK Market Abuse Regulation Article 19
On 27 March 2026, 3i Group plc (the "Company") (LEI: 35GDVHRBMFE7NWATNM84) was
notified that on 26 March 2026 Simon Borrows, a Director and person
discharging managerial responsibilities and certain Persons Closely Associated
("PCA") with him, purchased an aggregate of 350,147 ordinary shares of 73
19/22p each (ISIN: GB00B1YW4409) in the Company ("Shares") at a price of
£25.55 per Share.
The PCAs comprise a number of family trusts, each of which is a PCA with Simon
Borrows for the purposes of the UK Market Abuse Regulation.
Simon Borrows is Trustee of these trusts and for the purposes of the UK Market
Abuse Regulation is deemed to exercise control over their investment
decisions.
The transactions took place as follows:
Director/PCA Number of Shares purchased
Simon Borrows 39,123
The Borrows 2015 Number 1 Discretionary Settlement 19,561
The Borrows 2015 Number 2 Discretionary Settlement 19,561
The Borrows 2015 Number 3 Discretionary Settlement 19,561
The Borrows 2016 Number 1 Discretionary Settlement 19,561
The Borrows 2016 Number 2 Discretionary Settlement 19,561
The Borrows 2016 Number 3 Discretionary Settlement 19,561
Borrows 2018 No 1 Settlement 29,342
Borrows 2018 No 2 Settlement 29,342
Borrows 2018 No 3 Settlement 29,342
The Borrows 2021 No.1 Discretionary Settlement 15,649
The Borrows 2021 No.2 Discretionary Settlement 15,649
The Borrows 2021 No.3 Discretionary Settlement 15,649
The Borrows Grandchildrens Settlement 58,685
The place of the transactions was the London Stock Exchange.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHPPUUWWUPQGRM
Copyright 2019 Regulatory News Service, all rights reserved